Heisterberg L
J Perinat Med. 1984;12(1):43-5. doi: 10.1515/jpme.1984.12.1.43.
Concentrations of metronidazole and its hydroxy metabolite (I) were determined by a specific chromatographic method in blood, placenta and fetus from 10 women receiving oral metronidazole prior to legal first trimester abortion. In one woman given 2 g of metronidazole 9 hours before abortion, placenta and plasma levels were 6.6 micrograms/g and 13.4 micrograms/ml, respectively. The corresponding values for the hydroxy metabolite (I) were 1.8 micrograms/g and 5.6 micrograms/ml. In nine women receiving 400 mg metronidazole 1 hour before abortion, concentrations of metronidazole in plasma ranged from less than 0.1 to 9.4 micrograms/ml, in placenta from less than 0.1 to 6.3 micrograms/g, and in a fetal tissue from 1.9 to 3.0 micrograms/g. The concentrations of hydroxy metabolite (I) in plasma and placenta and fetal tissue all ranged below those of metronidazole.
采用特定的色谱方法,测定了10名在孕早期合法堕胎前口服甲硝唑的女性血液、胎盘和胎儿中甲硝唑及其羟基代谢物(I)的浓度。在一名堕胎前9小时服用2克甲硝唑的女性中,胎盘和血浆水平分别为6.6微克/克和13.4微克/毫升。羟基代谢物(I)的相应值为1.8微克/克和5.6微克/毫升。在9名堕胎前1小时服用400毫克甲硝唑的女性中,血浆中甲硝唑浓度范围为低于0.1至9.4微克/毫升,胎盘中为低于0.1至6.3微克/克,胎儿组织中为1.9至3.0微克/克。血浆、胎盘和胎儿组织中羟基代谢物(I)的浓度均低于甲硝唑的浓度。